Peter Park‘s Park West Asset Management has recently reported its position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) through a 13G filing with the Securities and Exchange Commission. According to the filing, Park West owns 690,000 shares of Eagle Pharmaceutical and the stake, which is passive by nature, amasses 4.4% of the company’s outstanding common stock.
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Park West Asset Management LLC | 690,000 | 0 | 690,000 | 0 | 690,000 | 4.4% |
Peter S. Park | 690,000 | 0 | 690,000 | 0 | 690,000 | 4.4% |
Follow Peter S. Park's Park West Asset Management
Page 1 of 9 SEC Filing
EAGLE PHARMACEUTICALS, INC. |
(Name of Issuer) |
COMMON STOCK, $0.001 PAR VALUE PER SHARE |
(Title of Class of Securities) |
269796108 |
(CUSIP Number) |
December 31, 2015 |
(Date of Event Which Requires Filing of this Statement) |